a month ago
LLY
AnalystsCarter GouldCarter Gould's Stock Forecasts
AnalystsCarter Gould
Analyst Ranking
Top 11%
#565 out of 5510 analysts
Average Return
+9.41%
Win Rate
59%91 out of 153
Risk vs Reward
Poor
Good
Carter Gould's 5 best and worst ratings
| Name / Ticker | Gain/Loss | Entry Price | Exit Price | Period | Rating |
|---|---|---|---|---|---|
Reata Pharmaceuticals IncRETA | +334.02% | $38.27 | $166.10 | 2022-11-09 - 2023-08-01 | Strong Buy |
Skillsoft CorpSKIL | +290.64% | $5.45 | $21.29 | 2024-04-16 - 2025-04-15 | Strong Buy |
Vor Biopharma IncVOR | +144.85% | $16.50 | $40.40 | 2024-08-14 - 2025-08-13 | Strong Buy |
Travere Therapeutics IncTVTX | +100.11% | $17.57 | $35.16 | 2024-11-01 - 2025-10-31 | Strong Buy |
Vaxcyte IncPCVX | +94.53% | $31.26 | $60.81 | 2025-04-22 - 2026-04-22 | Strong Buy |
Carter Gould Analyst Color
Get additional color on Carter Gould's coverage of popular stocks
a month ago
VRTX
a month ago
ABBV
a month ago
BMY
a month ago
REGN
2 months ago
LLY
2 months ago
ABBV
4 months ago
LLY
5 months ago
BMY
5 months ago
ABBV
7 months ago
GILD
10 months ago
NUVL
10 months ago
LLY
a year ago
ABBV
a year ago
LLY
a year ago
PFE
a year ago
MRK
a year ago
LLY
a year ago
GILD
2 years ago
NBIX
2 years ago
TVTX
2 years ago
LLY
2 years ago
ABBV
2 years ago
TVTX
2 years ago
REGN
Carter Gould's Stock Coverage
| Name / Ticker | No. Ratings | Rating | Price Target | Upside/Downside | Action | Date |
|---|---|---|---|---|---|---|
Amgen IncAMGN | 21 | Hold | $400.00 | +4.58% | Reiterates | 4 days ago |
Eli Lilly & CoLLY | 18 | Strong Buy | $1,410.00 | +25.56% | Maintains | a month ago |
Gilead Sciences IncGILD | 20 | Strong Buy | $155.00 | +7.04% | Reiterates | a month ago |
Vertex Pharmaceuticals IncVRTX | 5 | Strong Buy | $595.00 | +15.63% | Maintains | a month ago |
Abbvie IncABBV | 22 | Strong Buy | $285.00 | +11.76% | Maintains | a month ago |
Bristol Myers Squibb CoBMY | 19 | Hold | $59.00 | -7.45% | Maintains | a month ago |
Regeneron Pharmaceuticals IncREGN | 20 | Strong Buy | $795.00 | +0.22% | Maintains | a month ago |
Pfizer IncPFE | 17 | Hold | $27.00 | -2.35% | Reiterates | 2 months ago |
Merck & Co IncMRK | 13 | Hold | $120.00 | -17.08% | Reiterates | 2 months ago |
Nuvalent IncNUVL | 2 | Strong Buy | $112.00 | -9.65% | Maintains | 10 months ago |
Vaxcyte IncPCVX | 1 | Strong Buy | N/A | N/A | Initiates Coverage On | a year ago |
Neurocrine Biosciences IncNBIX | 11 | Strong Buy | $165.00 | N/A | Maintains | 2 years ago |
Travere Therapeutics IncTVTX | 6 | Strong Buy | $20.00 | N/A | Maintains | 2 years ago |
Biogen IncBIIB | 22 | Hold | $180.00 | N/A | Maintains | 2 years ago |
Vor Biopharma IncVOR | 4 | Strong Buy | $60.00 | N/A | Maintains | 2 years ago |
Barinthus Biotherapeutics PLCBRNS | 1 | Strong Buy | $3.00 | N/A | Maintains | 2 years ago |
Geron CorpGERN | 1 | Strong Buy | $9.00 | N/A | Initiates Coverage On | 2 years ago |
Cytokinetics IncCYTK | 2 | Strong Buy | $95.00 | N/A | Maintains | 2 years ago |
Skillsoft CorpSKIL | 5 | Strong Buy | $20.00 | N/A | Maintains | 2 years ago |
Arcellx IncACLX | 4 | Strong Buy | $73.00 | N/A | Maintains | 3 years ago |
Allakos IncALLK | 4 | Strong Sell | $1.00 | N/A | Maintains | 3 years ago |
Reata Pharmaceuticals IncRETA | 7 | Hold | $172.00 | N/A | Downgrades | 3 years ago |
Alector IncALEC | 2 | Strong Buy | $12.00 | N/A | Maintains | 3 years ago |
Gossamer Bio IncGOSS | 6 | Hold | $120.00 | N/A | Maintains | 3 years ago |
Molecular Templates IncMTEM | 3 | Strong Buy | $15.00 | N/A | Maintains | 4 years ago |
Applied Therapeutics IncAPLT | 4 | Hold | $2.25 | N/A | Maintains | 4 years ago |
Paycom Software IncPAYC | 1 | Hold | $380.00 | N/A | Maintains | 5 years ago |
Acceleron Pharma IncXLRN | 3 | Hold | $180.00 | N/A | Downgrades | 5 years ago |
Celgene CorpCELG | 3 | Hold | N/A | N/A | Downgrades | 7 years ago |
Incyte CorpINCY | 3 | Hold | $82.00 | N/A | Downgrades | 8 years ago |
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.